Xenleta

lefamulin · Nabriva Therapeutics AG

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Xenleta, covering 2024-06-17 to 2025-04-29. Get the full timeline:

Most recent: EMA Authorised: Xenleta (lefamulin acetate) — Nabriva Therapeutics Ireland DAC